HMG-COA REDUCTASE INHIBITORS (STATINS) ASSOCIATED TENDON RUPTURE: AN ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE REPORTING SYSTEM

被引：0
|
作者：
Rafi, J. A. [1 ]
Arabyat, R. [1 ]
Chen, C. [1 ]
Raisch, D. W. [1 ]
机构：
[1] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.066
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV1
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [11] Levetiracetam-induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database
    Carnovale, Carla
    Gentili, Marta
    Antoniazzi, Stefania
    Clementi, Emilio
    Radice, Sonia
    MUSCLE & NERVE, 2017, 56 (06) : E176 - E178
  • [12] HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview
    Balasubramanian, Rajkapoor
    Maideen, Naina M. P.
    CURRENT DRUG METABOLISM, 2021, 22 (05) : 328 - 341
  • [13] Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System
    Wei, Chunyan
    Yin, Wanhong
    He, Zhiyao
    Wu, Bin
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [14] Population Pharmacodynamic Analysis of HMG-CoA Reductase Inhibitors (Statins) in Japanese Adult Patients Based on the In-Hospital Medical Records
    Nomura, H.
    Kakara, M.
    Yamasaki, T.
    Fukae, M.
    Hirota, T.
    Hirakawa, M.
    Ieiri, I.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 708 - 708
  • [15] Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database
    Xu, Ye
    Yan, Cilin
    Zhao, Ying
    Li, Dandan
    Guo, Mingxing
    Cui, Xiangli
    CANCER MEDICINE, 2023, 12 (08): : 9167 - 9174
  • [16] LEVETIRACETAM-INDUCED RHABDOMYOLYSIS: ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE EVENT REPORTING SYSTEM DATABASE Reply
    Casanova-Molla, J.
    Valls-Sole, J.
    MUSCLE & NERVE, 2017, 56 (06) : E178 - E178
  • [17] Disproportionality analysis of emotional and mood disturbances with statins using the Food and Drug Administration adverse event reporting system
    Patterson, Catherine
    Alberdi, Mikel
    Scheer, Darren
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 346 - 346
  • [18] Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS)
    Li, Xianlin
    Shang, Nan
    Yan, Qianci
    Yue, Xiunan
    Liu, Yang
    Zheng, Xiaojun
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 183 - 192
  • [19] Priapism associated with antiepileptic drugs: a disproportionality analysis in the food and drug administration's adverse event reporting system
    Pejcic, A.
    Milosavljevic, M.
    Milosavljevic, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S438 - S438
  • [20] Erythema multiforme associated with the immune checkpoint inhibitors: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System
    Godfrey, Hannah
    Leibovit-Reiben, Zachary
    Jedlowski, Patrick
    Thiede, Rebecca
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1233 - 1234
12345